These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 17181148)
1. A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators. Labrie P; Maddaford SP; Fortin S; Rakhit S; Kotra LP; Gaudreault RC J Med Chem; 2006 Dec; 49(26):7646-60. PubMed ID: 17181148 [TBL] [Abstract][Full Text] [Related]
2. A comparative molecular field and comparative molecular similarity indices analyses (CoMFA and CoMSIA) of N-phenyl-N'-(2-chloroethyl)ureas targeting the colchicine-binding site as anticancer agents. Fortin S; Labrie P; Moreau E; Wei L; Kotra LP; C-Gaudreault R Bioorg Med Chem; 2008 Feb; 16(4):1914-26. PubMed ID: 18023585 [TBL] [Abstract][Full Text] [Related]
3. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA. Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators. Globisch C; Pajeva IK; Wiese M Bioorg Med Chem; 2006 Mar; 14(5):1588-98. PubMed ID: 16307883 [TBL] [Abstract][Full Text] [Related]
5. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists. Doddareddy MR; Cho YS; Koh HY; Pae AN Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074 [TBL] [Abstract][Full Text] [Related]
6. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models. Bhongade BA; Gadad AK J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035 [TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR studies of insecticidal anthranilic diamides as ryanodine receptor activators using CoMFA, CoMSIA and DISCOtech. Liu GY; Ju XL; Cheng J; Liu ZQ Chemosphere; 2010 Jan; 78(3):300-6. PubMed ID: 19914677 [TBL] [Abstract][Full Text] [Related]
8. Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors. Müller H; Pajeva IK; Globisch C; Wiese M Bioorg Med Chem; 2008 Mar; 16(5):2448-62. PubMed ID: 18083034 [TBL] [Abstract][Full Text] [Related]
9. Molecular modeling of triazine type MDR modulators using CoMFA and CoMSIA approaches. Tsakovska IM; Pajeva IK SAR QSAR Environ Res; 2002; 13(3-4):487-98. PubMed ID: 12184389 [TBL] [Abstract][Full Text] [Related]
10. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase. Lu P; Wei X; Zhang R Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589 [TBL] [Abstract][Full Text] [Related]
11. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA. Puntambekar DS; Giridhar R; Yadav MR Eur J Med Chem; 2006 Nov; 41(11):1279-92. PubMed ID: 16919851 [TBL] [Abstract][Full Text] [Related]
13. Development of new CoMFA and CoMSIA 3D-QSAR models for anti-inflammatory phthalimide-containing TNFalpha modulators. Avila CM; Romeiro NC; da Silva GM; Sant'Anna CM; Barreiro EJ; Fraga CA Bioorg Med Chem; 2006 Oct; 14(20):6874-85. PubMed ID: 16843662 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein. Raad I; Terreux R; Richomme P; Matera EL; Dumontet C; Raynaud J; Guilet D Bioorg Med Chem; 2006 Oct; 14(20):6979-87. PubMed ID: 16824763 [TBL] [Abstract][Full Text] [Related]
15. Three-dimensional quantitative structure-activity relationship study for phenylsulfonyl carboxylates using CoMFA and CoMSIA. Liu X; Yang Z; Wang L Chemosphere; 2003 Dec; 53(8):945-52. PubMed ID: 14505717 [TBL] [Abstract][Full Text] [Related]
17. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models. Puntambekar DS; Giridhar R; Yadav MR Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576 [TBL] [Abstract][Full Text] [Related]
18. Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists. Zhou YJ; Zhu LP; Tang Y; Ye DY Eur J Med Chem; 2007 Jul; 42(7):977-84. PubMed ID: 17331624 [TBL] [Abstract][Full Text] [Related]
19. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations. He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745 [TBL] [Abstract][Full Text] [Related]